Clinical TrialsSearch results
Number of results: 2560
Other
- A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Japanese Subjects with Advanced Solid Tumors
- Advanced Solid Tumors
- Hibi Kazushige
- 2022-11-28
Recruiting
- A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid Tumors
- Solid Tumors
- Ueda Eiji
- 2022-05-25
Other
- A phase 1b study of S-151128 in participants with knee osteoarthritis
- patients with knee osteoarthritis
- Juan Carlos Gomez
- 2023-11-19
Not yet recruiting
- A Phase 1b/2 Study of I-DXd in Combination with Atezolizumab with or without Carboplatin in First-Line ES-SCLC
- Extensive-stage Small Cell Lung Cancer
- Inoguchi Akihiro
- 2024-05-17
Recruiting
- A Phase 1b/2 Study of Tafasitamab, Tafasitamab Plus Lenalidomide, Tafasitamab Plus Parsaclisib, and Tafasitamab Plus Lenalidomide in Combination With R-CHOP in Japanese Participants With Non-Hodgkin Lymphoma
- Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma
- Ueda Eiji
- 2021-02-12
Other
- A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phase
- Chronic myelogenous leukemia
- Tokyo STI Study Group
- 2009-05-01
Other
- A phase 2 multicenter study evaluating the safety and efficacy of Nilotinib in patients with Imatinib-resistant/intolerant Ph+CML in chronic phase
- Chronic myelogenous leukemia
- Shimousa Hematology Study Group
- 2009-06-01
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Recruiting
- A phase 2 study of S-005151 in patients with dystrophic epidermolysis bullosa to evaluate the efficacy for intractable ulcers
- dystrophic epidermolysis bullosa
- Juan Carlos Gomez
- 2022-10-14
Not yet recruiting
- A Phase 2 Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)
- Rectal cancer
- Ishibashi Hideyasu
- 2023-02-23